miR-766-5p Targets Super-Enhancers by Downregulating CBP and BRD4
Open Access
- 5 August 2021
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 81 (20) , 5190-5201
Abstract
Super-enhancers (SE) are clusters of transcription enhancers that drive gene expression. SEs are typically characterized by high levels of acetylation of histone H3 lysine 27 (H3K27ac), which is catalyzed by the histone lysine acetyltransferase CREB binding protein (CBP). Cancer cells frequently acquire tumor-specific SEs at key oncogenes, such as MYC, which induce several hallmarks of cancer. BRD4 is recruited to SEs and consequently functions as an epigenetic reader to promote transcription of SE-marked genes in cancer cells. miRNAs can be potent candidates for nucleic acid therapeutics for cancer. We previously identified miR-766-5p as a miRNA that downregulated MYC expression and inhibited cancer cell growth in vitro. In this study, we show that miR-766-5p directly targets CBP and BRD4. Concurrent suppression of CBP and BRD4 cooperatively downregulated MYC expression in cancer cells but not in normal cells. Chromatin immunoprecipitation analysis revealed that miR-766-5p reduced levels of H3K27ac at MYC SEs via CBP suppression. Moreover, miR-766-5p suppressed expression of a BRD4-NUT fusion protein that drives NUT midline carcinoma. In vivo administration of miR-766-5p suppressed tumor growth in two xenograft models. Collectively, these data suggest that targeting SEs using miR-766-5p–based therapeutics may serve as an effective strategy for the treatment of MYC-driven cancers. Significance: This study demonstrates that miR-766-5p targets CBP and BRD4, which can mitigate the protumorigenic consequences of SEs and oncogenic fusion proteins.Keywords
All Related Versions
Funding Information
- KAKENHI (18H02688, 19K07709)
This publication has 55 references indexed in Scilit:
- Inhibition of Myc family proteins eradicates KRas-driven lung cancer in miceGenes & Development, 2013
- Transcriptional Amplification in Tumor Cells with Elevated c-MycCell, 2012
- MYC on the Path to CancerCell, 2012
- Frat Is a Phosphatidylinositol 3-Kinase/Akt-Regulated Determinant of Glycogen Synthase Kinase 3β Subcellular Localization in Pluripotent CellsMolecular and Cellular Biology, 2012
- Distinct roles of GCN5/PCAF‐mediated H3K9ac and CBP/p300‐mediated H3K18/27ac in nuclear receptor transactivationThe EMBO Journal, 2010
- Frat oncoproteins act at the crossroad of canonical and noncanonical Wnt-signaling pathwaysOncogene, 2009
- Up-regulation of C-Terminal Tensin-like Molecule Promotes the Tumorigenicity of Colon Cancer through β-CateninCancer Research, 2009
- p53 represses c-Myc through induction of the tumor suppressor miR-145Proceedings of the National Academy of Sciences, 2009
- Smad4 cooperates with lymphoid enhancer-binding factor 1/T cell-specific factor to increase c- myc expression in the absence of TGF-β signalingProceedings of the National Academy of Sciences, 2006
- Characterization of 21 newly established esophageal cancer cell linesCancer, 1992